Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis
- PMID: 21799073
- PMCID: PMC3208662
- DOI: 10.1164/rccm.201102-0271OC
Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis
Abstract
Rationale: Sepsis syndrome is characterized by inappropriate amplified systemic inflammatory response and bacteremia that promote multiorgan failure and mortality. Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates a pleiotropic cytoprotective defense program including antioxidants and protects against several inflammatory disorders by inhibiting oxidative tissue injuries. However, the role of enhanced Nrf2 activity in modulating innate immune responses to microbial infection and pathogenesis of sepsis is unclear.
Objectives: To determine whether Nrf2 in myeloid leukocytes alters inflammatory response and protects against sepsis.
Methods: Mice with deletion of Nrf2 or kelch-like ECH-associated protein (Keap1) in myeloid leukocyte cells and respective floxed controls were subjected to cecal ligation and puncture-induced sepsis and were assessed for survival, organ injury, systemic inflammation, and bacteremia. Using LPS-stimulated peritoneal macrophages, Toll-like receptor (TLR) 4 surface trafficking and downstream signaling events were analyzed.
Measurements and main results: Mortality, organ injury, circulating levels of inflammatory mediators, and bacteremia were markedly reduced in LysM-Keap1(-/-) compared with respective floxed controls (Keap1(f/f) or Nrf2(f/f)) and significantly elevated in LysM-Nrf2(-/-) mice after cecal ligation and puncture. Peritoneal macrophages from septic LysM-Keap1(-/-) mice showed a greater bacterial phagocytic activity compared with LysM-Nrf2(-/-) and floxed controls. LPS stimulation resulted in greater reactive oxygen species-induced cell surface transport of TLR4 from trans-Golgi network and subsequent TLR4 downstream signaling (recruitment of MYD88 and TRIF, phosphorylation of IkB and IRF3, and cytokine expression) in macrophages of LysM-Nrf2(-/-) compared with LysM-Keap1(-/-) mice and floxed controls.
Conclusions: Our study shows that Nrf2 acts as a critical immunomodulator in leukocytes, controls host inflammatory response to bacterial infection, and protects against sepsis.
Figures
Similar articles
-
NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice.J Immunol. 2010 Jul 1;185(1):569-77. doi: 10.4049/jimmunol.0902315. Epub 2010 May 28. J Immunol. 2010. PMID: 20511556 Free PMC article.
-
Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.Toxicol Sci. 2009 Mar;108(1):35-47. doi: 10.1093/toxsci/kfn267. Epub 2009 Jan 6. Toxicol Sci. 2009. PMID: 19129213 Free PMC article.
-
The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.J Biol Chem. 2013 Aug 9;288(32):23009-20. doi: 10.1074/jbc.M113.478545. Epub 2013 Jun 25. J Biol Chem. 2013. PMID: 23801334 Free PMC article.
-
Nrf2 protects against airway disorders.Toxicol Appl Pharmacol. 2010 Apr 1;244(1):43-56. doi: 10.1016/j.taap.2009.07.024. Epub 2009 Jul 29. Toxicol Appl Pharmacol. 2010. PMID: 19646463 Review.
-
Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.Annu Rev Pharmacol Toxicol. 2007;47:89-116. doi: 10.1146/annurev.pharmtox.46.120604.141046. Annu Rev Pharmacol Toxicol. 2007. PMID: 16968214 Review.
Cited by
-
Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression.Nat Commun. 2024 Jul 21;15(1):6152. doi: 10.1038/s41467-024-50454-2. Nat Commun. 2024. PMID: 39034312 Free PMC article.
-
Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function.Adv Exp Med Biol. 2024;1459:159-195. doi: 10.1007/978-3-031-62731-6_8. Adv Exp Med Biol. 2024. PMID: 39017844 Review.
-
Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review.Neurooncol Adv. 2023 Dec 23;6(1):vdad160. doi: 10.1093/noajnl/vdad160. eCollection 2024 Jan-Dec. Neurooncol Adv. 2023. PMID: 38221979 Free PMC article. Review.
-
Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance.J Clin Invest. 2023 Dec 7;134(3):e174528. doi: 10.1172/JCI174528. J Clin Invest. 2023. PMID: 38060331 Free PMC article.
-
Hsa_circ_0007321 regulates Zika virus replication through miR-492/NFKBID/NF-κB signaling pathway.J Virol. 2023 Dec 21;97(12):e0123223. doi: 10.1128/jvi.01232-23. Epub 2023 Dec 5. J Virol. 2023. PMID: 38051045 Free PMC article.
References
-
- Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003;9:517–524 - PubMed
-
- Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28:108–121 - PubMed
-
- Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303–1310 - PubMed
-
- Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez, Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 5P50ES015903/ES/NIEHS NIH HHS/United States
- R01 GM079239/GM/NIGMS NIH HHS/United States
- P50 ES015903/ES/NIEHS NIH HHS/United States
- R01 ES011863/ES/NIEHS NIH HHS/United States
- R01 HL081205/HL/NHLBI NIH HHS/United States
- P50 HL084945/HL/NHLBI NIH HHS/United States
- P50HL084945/HL/NHLBI NIH HHS/United States
- HL081205/HL/NHLBI NIH HHS/United States
- R01 HL066109/HL/NHLBI NIH HHS/United States
- GM079239/GM/NIGMS NIH HHS/United States
- P30 ES003819/ES/NIEHS NIH HHS/United States
- HL66109/HL/NHLBI NIH HHS/United States
- R01 GM050401/GM/NIGMS NIH HHS/United States
- R56 ES011863/ES/NIEHS NIH HHS/United States
- GM50401/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases